[Ed. Note: Kyle Dennis runs BiotechBreakouts.com. He is an event-based trader, who prefers low-priced and small-cap biotech stocks.]
- 1 What’s FDA Insider Alert?
- 2 How this strategy works?
- 3 What you gonna get for your money?
- 4 Who is Kyle Dennis?
What’s FDA Insider Alert?
FDA Insider Alerts comes fully loaded with Daily Watch Lists, expert commentary, text and email trade alerts, and a library of educational content.
How this strategy works?
Take a look below:
The first step is to identify a company with an upcoming catalyst event, which just means the company will be releasing some important news about a drug they are working on.
Using a simple scan Kyle identified GALT which announced the release of some important data in early December.
Then he added GALT to his watch list and sent all his members the following details:
Galectin Therapeutics (GALT)
Catalyst Dates: Phase 2 NASH data expected in early December.
Buy Zone: $2.20 to $2.40
Profit Zone: $2.80 or higher
Stop Zone: $1.70 or below
He was looking to get into GALT between $2.20 and $2.40 approximately and then ride the catalyst news event to somewhere above $2.80 in profits.
On November 6 Kyle bought a nice 5,000 share position at $2.42.
This is where his strategy comes into play. Most traders would hold this stock through the news expecting for this stock to shoot up into the stratosphere, but how often do you really see that happen?
That’s right, very rarely.
We instead got into this stock about a month before the data release, looking to ride the stock into the data event – but NOT HOLD THROUGH!
Whether you choose to collect 5%, 10%, or 20% along the way into the news is up to you. My goal is not to be “too greedy” but take easy profits along the way and do it over, and over… and over again!
When GALT hit his target sell zone, that’s exactly what Kyle did, cashing in for 22%.
He hit his profit zone on November 13th, and he locked in his profits as you can clearly see when he sent members his alert.
Would you ever say no to $2,700 in profits? I wouldn’t either.
Now here is what is key.
I take that piece of the pie and move on to something new. I don’t take on the risk of actually holding through the data event. The stock “could” continue up higher, they “could” hit positive news, and it “could” double. But using this method, you can get realistic and repeatable gains. Over and over and over again.
With much less risk!
While I like to trade biotech stocks, I’m far from being a PhD or scientist!
I simply lock in my profits when they are available, and move on to find the next winning stock.
One thing I have learned, and as a trader you should know too, is when you make your trading game plan you stick to it. You are giving yourself the best opportunity to win.
Hundreds of trading “gurus” claim crazy, outsized profits.
How many are willing to show you their W-2s?
Kyle Dennis is. In 2015, he claimed exactly $838,353 in capital gains.
Did Kyle grow up rich? No. Just two years earlier he was saddled with $80,000 in college debt – earning just $32,658 in a dead end, entry level job.
In four years – he turned $15,253 into $2,855,475…
That’s a 15,971% return!
So – how did he do it?
In two words: biotech stocks.
And, no – Kyle isn’t some scientific genius. He’s not trying to pick the next Merck or Pfizer. With his unique 3-Step Strategy – he’s only in each stock for a few days.
Still can’t guess how he’s doing it? I’ll give you a clue…
Every one of his trades requires a catalyst.
Now Kyle is sharing the secrets behind his strategy in a special online training event.
If you’re lucky enough to attend – you’ll get a complete walkthrough of his strategy that’s taken him from broke college student to multi-millionaire.
What you gonna get for your money?
In This Special Online Event You’ll Learn:
– The Basics of Trading Biotech Stocks
– The Secret to Kyle’s 18,912% Return
– 10 Reasons Why Biotech Can Be Lucrative
– Powerful ‘Catalyst’ Profit Strategies
– How to Find Upcoming Biotech Catalysts
– Step-by-Step Methods to WIN Your Valuation
– And so much more!
Who is Kyle Dennis?
Check out what some of Kyle’s students are tweeting about him:
YOU could be his next success story! Your first step? Register for the event: